Pain：针灸可有效预防偏头痛复发和再加

记者从月初在京闭幕的2011年内经全球性研讨会上获悉，首都医科大学附属北京中医公立医院内经中心经临床研究成果证实，传统的中医内经疗法可有效防止痉挛的复发和加重。相关研究成果篇文章亦同公开发表在全球性知名药理学期刊《疼痛》上，踏入中国大陆首篇公开发表于该杂志的临床研究成果篇文章。该文还被全球性知名药理学生物化学部门 Faculty of 1000 medicine（千名药理学家）翻唱。

据明白，作为临床常见病之一，痉挛存活率高，且危害严重。目前，要务18岁~65岁人群的痉挛患病率高达9.3%，且有大幅升高趋势。内经治疗法头痛在中国从未有数千年的上曾。北京中医公立医院内经中心自2004年成立头痛专家门诊，组织起来了基于“栽王乐亭”、学学艺术大师贺普仁等多位知名内经学家治痛知识的头痛研究成果。

据该中心主任王麟鹏介绍，该项目作出单盲、双模拟、系统性的形式，在国内5家公立医院的内经科共招募140名无先兆痉挛病征，随机细分两两组，分别为治疗法两组（内经加治疗法）和实验两组（假针加氟桂利嗪）。两两组病征每周内经治疗法3次，每晚口服药物。结果显示，4周后，治疗法两组痉挛的有效更为严重率为59%，实验两组为40%；治疗法两组疼痛整年不等升高4.1天，实验两组不等升高1.9天。16周后，治疗法两组有效更为严重率为56%，实验两组为37%；治疗法两组疼痛整年不等升高 4.1天，实验两组不等升高2天。

研究成果人员据此视为，内经可以作为痉挛的防止复发和加重的方法，其治果也优于在此之后国外的相关研究成果。由于其研究成果方法的新颖和重要性，该篇文章还被全球性知名药理学生物化学部门“千名科学家”翻唱。（生物谷 Bioon.com）

doi:10.1016/j.pain.2011.04.006PMC:PMID:

Efficacy of acupuncture for migraine prophylaxis: A single-blinded, double-dummy, randomized controlled trial

Lin-Peng Wang,Xiao-Zhe Zhang,Jia Guo,Hui-Lin Liu,Yan Zhang,Cun-Zhi Liu,Jing-Hong Yi,Li-Ping Wang,Ji-Ping Zhao,Shan-Shan Li

Summary This multicenter, double-dummy trial suggested that acupuncture was more effective than flunarizine in decreasing days of migraine attacks. Abstract Insufficient clinical trial data were ailable to prove the efficacy of acupuncture for migraine prophylaxis. A multicenter, double-dummy, single-blinded, randomized controlled clinical trial was conducted at the outpatient departments of acupuncture at 5 hospitals in China to evaluate the effectiveness of acupuncture. A total of 140 patients with migraine without aura were recruited and assigned randomly to 2 different groups: the acupuncture group treated with verum acupuncture plus placebo and the control group treated with sham acupuncture plus flunarizine. Treated by acupuncture 3 times per week and drugs every night, patients from both groups were evaluated at week 0 (baseline), week 4, and week 16. The primary outcome was measured by the proportion of responders (defined as the proportion of patients with a reduction of migraine days by at least 50%). The secondary outcome measures included the number of migraine days, visual ogue scale (VAS, 0 to 10cm) for pain, as well as the physical and mental component summary scores of the 36-item short-form health survey (SF-36). The patients in the acupuncture group had better responder rates and fewer migraine days compared with the control group (P.05). The results suggested that acupuncture was more effective than flunarizine in decreasing days of migraine attacks, whereas no significantly differences were found between acupuncture and flunarizine in reduction of pain intensity and improvement of the quality of life.